info@woodslane.com.au
Contact us on (02) 8445 2300
For all customer service and order enquiries

WOODSLANE

Popular Subjects

Woodslane Online Catalogues

9781936287789 Add to Cart Academic Inspection Copy

Lymphoma

Description
Table of
Contents
Google
Preview
This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of lymphoma subtypes. Lymphoma includes: Details the most current management across the spectrum of lymphoma subtypes Expert contributors from across the US and Canada Multidisciplinary coverage and emphasis on emerging therapeutic options, cutting edge developments and clinical research with near-term potential in clinical management Series Description: Emerging Cancer Therapeutics is an invited review publication providing a thorough analysis of key clinical research related to cancer therapeutics, including a discussion and assessment of current evidence; current clinical best practice, and likely near future developments. There is an emphasis throughout on multidisciplinary approaches to the speciality, as well as on quality and outcomes analysis. Published three times a year, Emerging Cancer Therapeutics provides authoritative, thorough assessments of advances in therapeutics in all major areas of oncology, both solid and haematologic malignancies, with a focus on advances in medical and biological therapies with emerging clinical impact and encompassing new technologies with implications for management such as molecular imaging.
New Therapies in Hodgkin Lymphoma, Yasuhiro Oki and Anas Younes; Emerging Therapies in T-Cell Lymphoma, Alison J. Moskowitz and Steven M. Horwitz; Indolent Lymphoma: The Role and Impact of Novel Therapies, Stephen Smith and John William Sweetenham; Evolving Landscape in Mantle Cell Lymphoma: Emerging Trends and New Therapeutic Options, Andre Goy; Novel Pathways and Therapeutic Strategies for Aggressive B-Cell Lymphoma, Kieron Dunleavy, Cliona Grant, and Wyndham H. Wilson; Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphoma, Philip J. Bierman; Allogeneic Stem Cell Transplantation for Lymphoma, Stephen Mackinnon and Ronjon Chakraverty; Nontransplant-Based Salvage Therapy for Aggressive Lymphoma, Sophia Farooki and Michael Crump
Google Preview content